Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

IMMUDX LLC
Profile last edited on: 8/28/20      CAGE: 7SD63      UEI: D6NRPST2VJH5

Business Identifier: Next gneration sequencing for immune repertoire analysis.
Year Founded
2016
First Award
2018
Latest Award
2019
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10703 Winchelsea Drive
Austin, TX 78750
   (650) 488-3961
   info@immudxllc.com
   www.immudxllc.com
Location: Single
Congr. District: 10
County: Williamson

Public Profile

Headed up by perosn having many years experience in related space with two major corporations, ImmudX LLC is structured to transform immune system testing data into actionable patient care, tackling next generation sequencing for immune repertoire analysis.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$599,917
Phase II Dollars
$282,527
Total Awarded
$882,444

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2019 2 NIH $582,527
Project Title: A Cloud-Based System for Scalable; Privacy-Preserving; and Interactive Immune Repertoire Analysis in Vaccination and Infection
2018 1 NIH $299,917
Project Title: A High-Throughput Platform for Neo-Antigen Based Cancer Immunotherapy

Key People / Management

  Jun Xiao -- Founder and CEO

  Jun Xiao

Company News

There are no news available.